Treato is a technology company.
Treato has raised $15.0M across 1 funding round.
Treato has raised $15.0M in total across 1 funding round.
Treato has raised $15.0M in total across 1 funding round.
Treato is a health technology company founded in 2007 in Yehud, Israel, that builds a social health patient intelligence platform using patented analytics, big data, and natural language processing (NLP) to analyze billions of patient and caregiver discussions from blogs, forums, and social media.[3][4][5] It serves both consumers—offering an advertising-free site (treato.com) for patients to access real-life experiences about medications and conditions—and pharmaceutical companies through Treato Pharma, providing brand intelligence on patient opinions, competitive positioning, and engagement insights.[2][3][4] The platform solves the problem of inaccessible, unstructured patient voices by aggregating and making sense of them into actionable knowledge, empowering better-informed healthcare decisions and marketing strategies.[1][2][3]
Initially developed over three years by First Life Research and launched in 2011, Treato gained recognition as a "Cool Vendor" by Gartner for its innovative approach to turning disparate online conversations into meaningful insights.[2][3] It prioritizes patient-centricity, robust security, and nationwide accessibility to healthcare information.[1]
Treato emerged from First Life Research, which spent over three years developing the platform's novel technology to parse complex health discussions using expertise in human psychology, medical terminology, and NLP.[3] Founded in 2007 in Yehud, Israel, it was officially introduced on September 26, 2011, in San Francisco as the first tool to index the "social health web," analyzing over a billion patient posts to create a searchable database of real-life experiences.[3][5]
Key figures include Gideon, a visionary entrepreneur with two decades in large-scale data who saw big data's potential in healthcare; Ido, who joined as CEO in April 2012 after leading Commtouch Software and bringing venture experience from Reed Elsevier Ventures; and later leadership under Alaveli Srinu, a healthcare veteran with over 15 years of experience.[1][4] Early traction came from indexing massive user-generated content, earning praise from health strategists like Matthew Holt of Health 2.0 for unearthing patient insights systematically.[3]
Treato rides the wave of big data and AI in healthcare, specifically social listening and patient-generated intelligence, which gained momentum in the early 2010s as online health discussions exploded.[2][3][4] Its timing was ideal post-2011, when social media became a dominant source of unfiltered patient data, filling gaps in traditional research amid rising demands for patient-centered care and pharma personalization.[3]
Market forces like the growth of digital health, regulatory pushes for real-world evidence, and pharma's shift to patient engagement favor Treato, influencing the ecosystem by pioneering "voice of the patient" analytics—now a standard in health tech for better drug development and marketing.[2][3][4] It democratizes healthcare insights, breaking barriers to information and supporting trends toward accessible, tech-driven wellness.[1]
Treato is poised to evolve with advances in AI-driven NLP and real-time social data, potentially expanding into predictive analytics for patient outcomes or global markets beyond its U.S.-focused indexing.[3][4] Trends like personalized medicine, telehealth integration, and stricter data privacy will shape its path, amplifying its role in evidence-based pharma strategies amid growing health data volumes.
As a trailblazer in patient intelligence, Treato continues reimagining healthcare by centering technology on real voices, ensuring quality care remains accessible and informed.[1][2]
Treato has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series B in April 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2013 | $15.0M Series B |